financetom
financetom
/
Privacy policy
Website Privacy Policy

This privacy policy sets out how we, the website operator, collect, store and use any personal information we collect from you, or that you provide to us, through our website.

Collection of Personal Information

We may collect personal information about you when you use our website, for instance, when you contact us via email, or when you fill in a contact form on our website. The personal information we may collect includes your name, email address, and any other information you choose to provide to us.

Use of Personal Information

We use the personal information we collect from you for the following purposes:

a) to provide you with the information or services you request;

b) to process and respond to your inquiries and requests;

c) to send you marketing emails or newsletters if you have opted in to receive them;

d) for internal recordkeeping; and

e) to improve our services and website.

Disclosure of Personal Information

We may disclose your personal information to any third party if we are required to do so by law, or if we believe that such disclosure is necessary to protect our rights or the rights of others.

Retention of Personal Information

We will retain your personal information for as long as it is necessary for the purposes set out in this privacy policy. We will delete your personal information when it is no longer required, or when you request that it be deleted.

Access to and Correction of Personal Information

You have the right to request access to the personal information that we hold about you. If your personal information is incorrect or incomplete, you may request that it be corrected. To access or correct your personal information, please contact us using the contact details provided below.

Cookies and Tracking Technologies

Our website may use cookies and other tracking technologies to collect information about your use of our website. Cookies are small files that are placed on your computer or device when you visit our website. We use cookies to track your use of our website, remember your preferences, and improve your user experience. We may also use cookies to serve targeted advertising and measure the effectiveness of our advertising campaigns. You can set your browser to refuse cookies or to alert you when cookies are being sent. However, if you disable cookies, some features of our website may not function properly. We do not collect personal information for the purpose of targeting advertising. We do not sell or disclose any information about your use of our website to third parties.

Security of Personal Information

We take reasonable measures to protect the personal information we collect from loss, misuse, unauthorized access, disclosure, alteration, and destruction. However, please note that no internet transmission is ever fully secure or error-free. In particular, email sent to or from our website may not be secure. Therefore, you should take special care in deciding what information you send to us via email. Please keep this in mind when disclosing any personal information online, especially via email.

Related Articles >
Nvidia, SK to detail cooperation plan as Huang flags prolonged chip shortage 
Nvidia, SK to detail cooperation plan as Huang flags prolonged chip shortage 
Jun 7, 2026
SEOUL, June 7 (Reuters) - Nvidia ( NVDA ) and South Korea's SK are expected to announce a plan for cooperation between the two companies on Monday, with the boss of the U.S. chipmaker saying that the ongoing memory shortage would persist for quite a few years. A spokesperson for SK Hynix said group chairman Chey Tae-won and Nvidia (...
Nvidia CEO, SK chairman to announce cooperation plan on Monday - report
Nvidia CEO, SK chairman to announce cooperation plan on Monday - report
Jun 7, 2026
SEOUL, June 7 (Reuters) - Nvidia ( NVDA ) CEO Jensen Huang and SK Group chairman Chey Tae-won are set to announce a plan for cooperation between the two companies on Monday, according to a media report by Newsis. An SK Hynix spokesperson did not immediately reply to a request for comment. Huang told reporters on Sunday that he could...
Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports
Incyte nears up to $2 billion deal for blood disorder biotech Star, FT reports
Jun 7, 2026
June 7 (Reuters) - US biotech Incyte Pharma is nearing a deal for up to $2 billion to buy blood disorder drug developer Star Therapeutics, the Financial Times reported on Sunday, citing people familiar with the matter. The biotechnology company is set to pay $1.25 billion upfront in cash to Star's venture capital backers and a further $750 million based...
BRIEF-Incyte Nears Up To $2 Billion Deal For Blood Disorder Biotech Star - FT
BRIEF-Incyte Nears Up To $2 Billion Deal For Blood Disorder Biotech Star - FT
Jun 7, 2026
June 7 (Reuters) - * INCYTE NEARS UP TO $2BN DEAL FOR BLOOD DISORDER BIOTECH STAR - FT Source text: [https://tinyurl.com/4fdjr644] Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved